nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—MUC2—bile duct cancer	0.864	1	CbGaD
Pranlukast—ABCC2—bile duct—bile duct cancer	0.00933	0.21	CbGeAlD
Pranlukast—MUC2—gall bladder—bile duct cancer	0.00889	0.2	CbGeAlD
Pranlukast—ABCC2—bile—bile duct cancer	0.00717	0.161	CbGeAlD
Pranlukast—MUC2—pancreas—bile duct cancer	0.0041	0.0922	CbGeAlD
Pranlukast—MUC2—liver—bile duct cancer	0.00261	0.0586	CbGeAlD
Pranlukast—IL5—lymph node—bile duct cancer	0.0026	0.0585	CbGeAlD
Pranlukast—CYSLTR1—pancreas—bile duct cancer	0.0023	0.0516	CbGeAlD
Pranlukast—TNF—lymph node—bile duct cancer	0.002	0.045	CbGeAlD
Pranlukast—NFKB1—liver—bile duct cancer	0.00149	0.0334	CbGeAlD
Pranlukast—NFKB1—lymph node—bile duct cancer	0.00114	0.0256	CbGeAlD
Pranlukast—CYSLTR1—lymph node—bile duct cancer	0.00112	0.0252	CbGeAlD
Pranlukast—ABCC2—liver—bile duct cancer	0.000584	0.0131	CbGeAlD
Pranlukast—ABCC2—lymph node—bile duct cancer	0.000448	0.0101	CbGeAlD
Pranlukast—CYP2C9—liver—bile duct cancer	0.000389	0.00875	CbGeAlD
Pranlukast—CYP3A4—liver—bile duct cancer	0.000297	0.00667	CbGeAlD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—bile duct cancer	0.000108	0.00118	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—NRAS—bile duct cancer	0.000106	0.00116	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—NRAS—bile duct cancer	0.000106	0.00115	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—KRAS—bile duct cancer	0.000105	0.00115	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—GNAS—bile duct cancer	0.000105	0.00114	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—HRAS—bile duct cancer	0.000104	0.00114	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—KRAS—bile duct cancer	0.000104	0.00113	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—bile duct cancer	0.000104	0.00113	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—IL6—bile duct cancer	0.000104	0.00113	CbGpPWpGaD
Pranlukast—TNF—TGF-beta Receptor Signaling—HRAS—bile duct cancer	0.000103	0.00113	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—TP53—bile duct cancer	0.000102	0.00111	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RNF43—bile duct cancer	0.000101	0.0011	CbGpPWpGaD
Pranlukast—NFKB1—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—bile duct cancer	9.98e-05	0.00109	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TP53—bile duct cancer	9.96e-05	0.00108	CbGpPWpGaD
Pranlukast—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—bile duct cancer	9.88e-05	0.00108	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bile duct cancer	9.88e-05	0.00108	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—bile duct cancer	9.88e-05	0.00108	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TGFB1—bile duct cancer	9.82e-05	0.00107	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	9.78e-05	0.00106	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—PTGS2—bile duct cancer	9.71e-05	0.00106	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—TGFB1—bile duct cancer	9.68e-05	0.00105	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—ERBB2—bile duct cancer	9.43e-05	0.00103	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—TP53—bile duct cancer	9.34e-05	0.00102	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—bile duct cancer	9.33e-05	0.00102	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—IL6—bile duct cancer	9.29e-05	0.00101	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—NRAS—bile duct cancer	9.22e-05	0.001	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—bile duct cancer	9.22e-05	0.001	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—TP53—bile duct cancer	9.2e-05	0.001	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—KRAS—bile duct cancer	9.17e-05	0.000998	CbGpPWpGaD
Pranlukast—IL5—Immune System—HGF—bile duct cancer	9.11e-05	0.000991	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—KRAS—bile duct cancer	9.1e-05	0.000991	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 cascade initiated on plasma membrane—IL6—bile duct cancer	9.03e-05	0.000983	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—HRAS—bile duct cancer	9.01e-05	0.000981	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—HRAS—bile duct cancer	8.95e-05	0.000974	CbGpPWpGaD
Pranlukast—NFKB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—bile duct cancer	8.95e-05	0.000974	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	8.87e-05	0.000966	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—HRAS—bile duct cancer	8.86e-05	0.000964	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—bile duct cancer	8.8e-05	0.000958	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 dependent cascade initiated on endosome—IL6—bile duct cancer	8.78e-05	0.000956	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—IL6—bile duct cancer	8.78e-05	0.000956	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—ERBB2—bile duct cancer	8.73e-05	0.00095	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	8.67e-05	0.000944	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—IL6—bile duct cancer	8.63e-05	0.000939	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—IL6—bile duct cancer	8.56e-05	0.000932	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—MMP9—bile duct cancer	8.52e-05	0.000928	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Receptor Signaling Pathway—HRAS—bile duct cancer	8.49e-05	0.000924	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—IL6—bile duct cancer	8.48e-05	0.000923	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 9 (TLR9) Cascade—IL6—bile duct cancer	8.48e-05	0.000923	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—IL6—bile duct cancer	8.42e-05	0.000917	CbGpPWpGaD
Pranlukast—NFKB1—MyD88:Mal cascade initiated on plasma membrane—IL6—bile duct cancer	8.33e-05	0.000907	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—GNAS—bile duct cancer	8.27e-05	0.0009	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TP53—bile duct cancer	8.09e-05	0.00088	CbGpPWpGaD
Pranlukast—NFKB1—MyD88-independent cascade—IL6—bile duct cancer	7.99e-05	0.00087	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—TP53—bile duct cancer	7.97e-05	0.000868	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—KRAS—bile duct cancer	7.94e-05	0.000864	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	7.93e-05	0.000864	CbGpPWpGaD
Pranlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—bile duct cancer	7.91e-05	0.000861	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—IL6—bile duct cancer	7.81e-05	0.00085	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—HRAS—bile duct cancer	7.79e-05	0.000848	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—HRAS—bile duct cancer	7.73e-05	0.000842	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—IL6—bile duct cancer	7.63e-05	0.00083	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—NRAS—bile duct cancer	7.62e-05	0.000829	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	7.59e-05	0.000827	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—bile duct cancer	7.59e-05	0.000826	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—NRAS—bile duct cancer	7.51e-05	0.000818	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—GNAS—bile duct cancer	7.51e-05	0.000818	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—NRAS—bile duct cancer	7.48e-05	0.000814	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL6—bile duct cancer	7.46e-05	0.000812	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—EGFR—bile duct cancer	7.42e-05	0.000808	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—SMAD4—bile duct cancer	7.41e-05	0.000807	CbGpPWpGaD
Pranlukast—NFKB1—Activated TLR4 signalling—IL6—bile duct cancer	7.19e-05	0.000783	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—NRAS—bile duct cancer	7.17e-05	0.000781	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TGFB1—bile duct cancer	7.08e-05	0.000771	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TGFB1—bile duct cancer	7.02e-05	0.000765	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	7.01e-05	0.000763	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TGFB1—bile duct cancer	6.95e-05	0.000757	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—EGFR—bile duct cancer	6.89e-05	0.00075	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—bile duct cancer	6.85e-05	0.000745	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—EGFR—bile duct cancer	6.81e-05	0.000742	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—IL6—bile duct cancer	6.76e-05	0.000736	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	6.76e-05	0.000736	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—HRAS—bile duct cancer	6.75e-05	0.000735	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IL6—bile duct cancer	6.69e-05	0.000729	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—NRAS—bile duct cancer	6.64e-05	0.000723	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	6.61e-05	0.00072	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—KRAS—bile duct cancer	6.56e-05	0.000714	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—EGFR—bile duct cancer	6.53e-05	0.000711	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—TGFB1—bile duct cancer	6.5e-05	0.000708	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—KRAS—bile duct cancer	6.47e-05	0.000704	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—IL6—bile duct cancer	6.46e-05	0.000703	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—KRAS—bile duct cancer	6.44e-05	0.000701	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—ERBB2—bile duct cancer	6.42e-05	0.000699	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TGFBR2—bile duct cancer	6.41e-05	0.000698	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	6.27e-05	0.000683	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—bile duct cancer	6.23e-05	0.000678	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—HRAS—bile duct cancer	6.19e-05	0.000674	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—GNAS—bile duct cancer	6.18e-05	0.000673	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—KRAS—bile duct cancer	6.17e-05	0.000672	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	6.15e-05	0.000669	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL6—bile duct cancer	6.09e-05	0.000663	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SMAD4—bile duct cancer	6.06e-05	0.00066	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—EGFR—bile duct cancer	6.05e-05	0.000658	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—IL6—bile duct cancer	6.02e-05	0.000656	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL6—bile duct cancer	5.95e-05	0.000647	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	5.86e-05	0.000638	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—bile duct cancer	5.83e-05	0.000634	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	5.81e-05	0.000632	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—bile duct cancer	5.78e-05	0.00063	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—bile duct cancer	5.72e-05	0.000623	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—KRAS—bile duct cancer	5.71e-05	0.000622	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—NRAS—bile duct cancer	5.7e-05	0.00062	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RNF43—bile duct cancer	5.7e-05	0.00062	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MET—bile duct cancer	5.67e-05	0.000618	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—SMAD4—bile duct cancer	5.65e-05	0.000615	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL6—bile duct cancer	5.58e-05	0.000608	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—HRAS—bile duct cancer	5.57e-05	0.000607	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL6—bile duct cancer	5.56e-05	0.000605	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—TGFB1—bile duct cancer	5.52e-05	0.000601	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—bile duct cancer	5.5e-05	0.000599	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TGFB1—bile duct cancer	5.29e-05	0.000576	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL6—bile duct cancer	5.29e-05	0.000576	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—bile duct cancer	5.27e-05	0.000574	CbGpPWpGaD
Pranlukast—IL5—Immune System—ERBB2—bile duct cancer	5.25e-05	0.000572	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—HRAS—bile duct cancer	5.25e-05	0.000571	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—EGFR—bile duct cancer	5.19e-05	0.000565	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	5.16e-05	0.000562	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—bile duct cancer	5.02e-05	0.000547	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—NRAS—bile duct cancer	4.97e-05	0.000541	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—KRAS—bile duct cancer	4.9e-05	0.000534	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IL6—bile duct cancer	4.9e-05	0.000533	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—NRAS—bile duct cancer	4.89e-05	0.000532	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—HRAS—bile duct cancer	4.86e-05	0.000529	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL6—bile duct cancer	4.83e-05	0.000526	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	4.78e-05	0.00052	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP2—bile duct cancer	4.73e-05	0.000515	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	4.68e-05	0.00051	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—bile duct cancer	4.65e-05	0.000506	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL6—bile duct cancer	4.64e-05	0.000505	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFBR2—bile duct cancer	4.6e-05	0.000501	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—GNAS—bile duct cancer	4.56e-05	0.000496	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—EGFR—bile duct cancer	4.45e-05	0.000485	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GNAS—bile duct cancer	4.44e-05	0.000483	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	4.43e-05	0.000482	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—NRAS—bile duct cancer	4.37e-05	0.000476	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—bile duct cancer	4.36e-05	0.000475	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—FAR2—bile duct cancer	4.35e-05	0.000474	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SMAD4—bile duct cancer	4.35e-05	0.000474	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MET—bile duct cancer	4.32e-05	0.000471	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—KRAS—bile duct cancer	4.28e-05	0.000466	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL6—bile duct cancer	4.23e-05	0.000461	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—KRAS—bile duct cancer	4.21e-05	0.000458	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—ERBB2—bile duct cancer	4.15e-05	0.000452	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	4.11e-05	0.000447	CbGpPWpGaD
Pranlukast—IL5—Immune System—NRAS—bile duct cancer	3.99e-05	0.000435	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—bile duct cancer	3.98e-05	0.000434	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—EGFR—bile duct cancer	3.98e-05	0.000434	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	3.93e-05	0.000428	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—KRAS—bile duct cancer	3.76e-05	0.00041	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HGF—bile duct cancer	3.7e-05	0.000403	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ERBB2—bile duct cancer	3.66e-05	0.000399	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL6—bile duct cancer	3.65e-05	0.000397	CbGpPWpGaD
Pranlukast—IL5—Immune System—EGFR—bile duct cancer	3.64e-05	0.000396	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HRAS—bile duct cancer	3.64e-05	0.000396	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP2—bile duct cancer	3.61e-05	0.000393	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—HRAS—bile duct cancer	3.57e-05	0.000389	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP9—bile duct cancer	3.56e-05	0.000387	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ERBB2—bile duct cancer	3.52e-05	0.000383	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL6—bile duct cancer	3.48e-05	0.000379	CbGpPWpGaD
Pranlukast—IL5—Immune System—KRAS—bile duct cancer	3.44e-05	0.000374	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—IL6—bile duct cancer	3.42e-05	0.000372	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ERBB2—bile duct cancer	3.39e-05	0.00037	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HRAS—bile duct cancer	3.2e-05	0.000348	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—ERBB2—bile duct cancer	3.16e-05	0.000344	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—NRAS—bile duct cancer	3.16e-05	0.000344	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—NRAS—bile duct cancer	3.14e-05	0.000342	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL6—bile duct cancer	3.06e-05	0.000333	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TGFB1—bile duct cancer	2.93e-05	0.000319	CbGpPWpGaD
Pranlukast—IL5—Immune System—HRAS—bile duct cancer	2.92e-05	0.000318	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MMP9—bile duct cancer	2.91e-05	0.000317	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—EGFR—bile duct cancer	2.88e-05	0.000313	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—FAR2—bile duct cancer	2.87e-05	0.000313	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—EGFR—bile duct cancer	2.86e-05	0.000311	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL6—bile duct cancer	2.8e-05	0.000305	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—NRAS—bile duct cancer	2.79e-05	0.000303	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—KRAS—bile duct cancer	2.72e-05	0.000296	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP9—bile duct cancer	2.71e-05	0.000295	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—KRAS—bile duct cancer	2.7e-05	0.000294	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—NRAS—bile duct cancer	2.68e-05	0.000291	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFBR2—bile duct cancer	2.6e-05	0.000283	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NRAS—bile duct cancer	2.58e-05	0.000281	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EGFR—bile duct cancer	2.54e-05	0.000276	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GNAS—bile duct cancer	2.51e-05	0.000273	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SMAD4—bile duct cancer	2.46e-05	0.000268	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—EGFR—bile duct cancer	2.44e-05	0.000265	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ERBB2—bile duct cancer	2.44e-05	0.000265	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NRAS—bile duct cancer	2.4e-05	0.000262	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TGFB1—bile duct cancer	2.4e-05	0.000261	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—KRAS—bile duct cancer	2.4e-05	0.000261	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EGFR—bile duct cancer	2.35e-05	0.000256	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—HRAS—bile duct cancer	2.31e-05	0.000251	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—KRAS—bile duct cancer	2.3e-05	0.000251	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HRAS—bile duct cancer	2.3e-05	0.00025	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TGFB1—bile duct cancer	2.23e-05	0.000243	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KRAS—bile duct cancer	2.22e-05	0.000242	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—bile duct cancer	2.21e-05	0.000241	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—bile duct cancer	2.2e-05	0.000239	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EGFR—bile duct cancer	2.19e-05	0.000238	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ERBB2—bile duct cancer	2.13e-05	0.000232	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—IDH2—bile duct cancer	2.13e-05	0.000231	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP9—bile duct cancer	2.09e-05	0.000228	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—KRAS—bile duct cancer	2.07e-05	0.000225	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—HRAS—bile duct cancer	2.04e-05	0.000222	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—bile duct cancer	1.98e-05	0.000215	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HRAS—bile duct cancer	1.96e-05	0.000213	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—bile duct cancer	1.95e-05	0.000212	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HRAS—bile duct cancer	1.89e-05	0.000206	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NRAS—bile duct cancer	1.85e-05	0.000202	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—IDH1—bile duct cancer	1.83e-05	0.000199	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—bile duct cancer	1.81e-05	0.000197	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—HRAS—bile duct cancer	1.76e-05	0.000191	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFB1—bile duct cancer	1.72e-05	0.000188	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EGFR—bile duct cancer	1.69e-05	0.000184	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—bile duct cancer	1.68e-05	0.000183	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NRAS—bile duct cancer	1.62e-05	0.000177	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KRAS—bile duct cancer	1.6e-05	0.000174	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EGFR—bile duct cancer	1.48e-05	0.000161	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—bile duct cancer	1.42e-05	0.000154	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—IDH2—bile duct cancer	1.4e-05	0.000153	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—KRAS—bile duct cancer	1.4e-05	0.000152	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ERBB2—bile duct cancer	1.38e-05	0.00015	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HRAS—bile duct cancer	1.36e-05	0.000148	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—bile duct cancer	1.3e-05	0.000141	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC5A5—bile duct cancer	1.21e-05	0.000131	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—IDH1—bile duct cancer	1.21e-05	0.000131	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HRAS—bile duct cancer	1.19e-05	0.000129	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP9—bile duct cancer	1.18e-05	0.000129	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—bile duct cancer	1.14e-05	0.000124	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.13e-05	0.000123	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NRAS—bile duct cancer	1.05e-05	0.000114	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFB1—bile duct cancer	9.75e-06	0.000106	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EGFR—bile duct cancer	9.56e-06	0.000104	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GNAS—bile duct cancer	9.37e-06	0.000102	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KRAS—bile duct cancer	9.03e-06	9.83e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—bile duct cancer	8.03e-06	8.74e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC5A5—bile duct cancer	7.95e-06	8.66e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HRAS—bile duct cancer	7.68e-06	8.36e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—bile duct cancer	7.35e-06	8e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GNAS—bile duct cancer	6.18e-06	6.73e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—bile duct cancer	5.03e-06	5.48e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—bile duct cancer	3.32e-06	3.61e-05	CbGpPWpGaD
